Skip to main content
. 2017 Feb 10;13(4):2495–2501. doi: 10.3892/ol.2017.5714

Table I.

Baseline patient characteristics.

Characteristic Whole cohort (n=287) G1 (n=93) G2 (n=90) G3 (n=104) P-values
Age, years 37.59±9.04 39.74±9.78 33.61±7.52 39.11±8.51 G1 vs. G2, P<0.05; G2 vs. G3, P<0.05; G1 vs. G3, P>0.05
Origin P<0.05
  Western Europe 61.8 65.6 95.4 37.2
  Eastern Europe 12.3 20.4 3.1   9.3
  Central/South America 4.0/10.9 1.5/4.7 1.5/0 2.3/38.4
  Africa 10.9   7.8 0 12.8
Smoking P<0.05
  Yes 32.0 29.0 44.3 24.0
  No 68.0 71.0 55.7 76.0
Anal intercourse P>0.05
  Yes 28.8 35.5 25.3 25.7
  No 71.2 64.5 74.7 74.3
Age at first sexual intercourse, years P>0.05
  ≤15 20.0 18.5 14.9 25.7
  16–19 56.1 53.3 66.7 49.5
  20–24 21.4 25.0 16.1 22.8
  ≥25   2.5   3.2 2.3   2.0
Lifetime sex partners P>0.05
  1   9.0 16.5 4.6   5.9
  2–5 46.2 42.9 46.0 49.5
  6–10 24.4 19.8 39.1 15.8
  >10 20.4 20.9 10.3 28.8
Marital status/stable partner P>0.05
  Yes 81.4 84.8 86.2 74.3
  No 18.6 15.2 13.8 25.7
History of worst cytological result of the cervix P>0.05
  Not specified 44.3 92.9 21.4 19.6
  PAP 2   8.6   1.2 1.4 19.6
  PAP 3   3.9   2.4 4.3   4.9
  PAP 3D 33.1   3.5 65.7 35.3
  PAP 4a   0.4 0 0   1.0
  PAP 4b   9.7 0 7.2 19.6

Data are presented as the mean ± standard deviation or %. G1, HIV-negative patients who underwent routine cervical cytology screening; G2, HIV-negative patients with at least one abnormal cytological (Pap)-smear result of the cervix; G3, HIV-infected patients who underwent routine cervical cytology screening; PAP, Papanicolaou (Munich nomenclature II).